Searched for
CORDIS
H&F weighs $9 billion-plus sale of medical device maker Cordis: ReportU.S. private equity firm Hellman & Friedman is exploring a sale of medical devices maker Cordis, aiming for a valuation exceeding $9 billio...- Make mum feel extra special this Mother's Day 2025 – city-wise guide to the best experiences in NZMother's Day 2025 is on May 11. It is a great chance to honour mothers. Auckland, Wellington, and Christchurch offer special experiences. Q...
- MedAlliance acquired by Cordis for $1.13 billionSwiss-based medical technology company MedAlliance has announced acquisition by Cordis for $1.13 billion. Cordis will play a pivotal role i...
- NFL-National Football League roundupFOOTBALL-NFL/ROUNDUP:NFL-National Football League roundup
- NFL-Highlights of Sunday's National Football League gamesNFL-HIGHLIGHTS/:NFL-Highlights of Sunday's National Football League games
- NFL-National Football League roundupNFL-ROUNDUP/:NFL-National Football League roundup
- Indian adtech firms face their moment of truth; struggle to automate and innovateLast week, digital marketing firm Vizury laid off a chunk of its employees, leaving just a core 50 member team behind. Ad Magnet, an ad net...
- Start-ups like SilverPush and Ice Cream Labs are bringing ad dollars from traditional media to online spaceThe company embeds a high-frequency signal inside a TV ad and captures a person’s response to it through the mobile phone- did they change ...
- Investors direct attention to ad tech startupsOne such player is Gurgaon-based SilverPush, which is luring traditional TV advertisers into the online arena.
- Google in talks to buy mobile advertising network InMobi to counter Facebook's ad dominanceSources said Google would soon initiate a technology due diligence of Bengaluru-based InMobi followed by discussions on commercial terms.
- Cost effect: Stents costing Rs 40,000 sold to you at Rs 1.2 lakhThe dealer price or the landed cost in India for a drug eluting stent (DES) is not more than Rs 40,000, often just Rs 20,000.
- InMobi 'pivots' to take on online Ad giants like Google, Acxiom, Experian directlyIt will see InMobi - combine data from clients with insights on consumer behaviour that it has gathered - create new marketing strategies f...
- Rivals to benefit as J&J exits from heart stentsThe decision of Johnson&Johnson to stop making its popular drug eluting stent has opened up new opportunities for competitors Abbott & Bost...
- J&J plans to cut 4,800 jobs in recastJohnson & Johnson will reduce its global work force by up to 4% to cut costs due to a slump in sales.
- No transfer pricing norms if no tax liabilityIf a foreign company does not have a liability to pay tax, the income-tax department cannot apply transfer pricing provisions on it.
Load More- NFL-National Football League roundup
